NCT06425900View on ClinicalTrials.gov

A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions

Acne Vulgaris

Interventions

DRUG

Winlevi (Clascoterone) cream 1%

Dosed twice daily (BID)

Trial Locations (1)

27262

Dermatology Consulting Services, PLLC, High Point

All Listed Sponsors

lead

Sun Pharmaceutical Industries Limited

INDUSTRY

NCT06425900 - A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients | Biotech Hunter | Biotech Hunter